Oligonucleotides Market Outlook 2034: Projected to Reach US$ 13.1 Billion by 2034, Driven by Expanding Applications in Biotechnology and Precision Medicine | TMR
02 déc. 2024 10h08 HE
|
Transparency Market Research
Wilmington, Delaware, Transparency Market Research Inc.:, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The global oligonucleotides market (mercado de oligonucleótidos) is poised for significant growth,...
e-therapeutics Announces Business Updates and Interim Results
31 oct. 2024 09h00 HE
|
e-therapeutics plc
LONDON, Oct. 31, 2024 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, today announced business...
invIOs raises €8.2 million in a Series A to finance pipeline progress in immuno-oncology
15 oct. 2024 04h30 HE
|
invIOs GmbH
Funding secures ongoing pipeline progress and achievement of preclinical and clinical milestones Oral small molecule INV501: collaboration with Dana-Farber Cancer Institute (DFCI) making good...
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
17 sept. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
NurExone Announces the Transfer of Manufacturing of the Active Element in ExoPTEN Drug to a Commercial GMP Manufacturer
01 août 2024 16h04 HE
|
NurExone Biologic Inc
NurExone Announces the Transfer of Manufacturing of the Active Element in ExoPTEN Drug to a Commercial GMP Manufacturer
ADARx Pharmaceuticals Appoints Ajim Tamboli, CFA as Chief Financial Officer
30 juil. 2024 09h05 HE
|
ADARx Pharmaceuticals
ADARx Pharmaceuticals Appoints Ajim Tamboli, CFA as Chief Financial Officer
ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer
02 avr. 2024 09h05 HE
|
ADARx Pharmaceuticals
ADARx Pharmaceuticals, next-generation RNA therapeutics developer, appoints Dr. Chris Storgard as Chief Medical Officer
Lyophilization Services for Biopharmaceuticals Market worth $3.58 Billion by 2028 - Exclusive Report by The Insight Partners
04 sept. 2023 10h08 HE
|
The Insight Partners
Pune, India, Sept. 04, 2023 (GLOBE NEWSWIRE) -- Lyophilization is a process of isolating a solid substance from a solution. It is also known as freeze-drying is a process. The process is carried by...
SiSaf Appoints Nikos Tzagkarakis in the New Role of Chief A.I. Officer
13 juil. 2023 04h00 HE
|
SiSaf Ltd
GUILDFORD, England, July 13, 2023 (GLOBE NEWSWIRE) -- RNA delivery and therapeutics company SiSaf Ltd announces that it has appointed Nikos Tzagkarakis in the newly created role of Chief A.I....
Ractigen Therapeutics Receives FDA Orphan Drug Designation for the novel oligonucleotide conjugate RAG-17 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
03 mars 2023 09h00 HE
|
Ractigen Therapeutics
JIANGSU, China, March 03, 2023 (GLOBE NEWSWIRE) -- Ractigen Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to RAG-17, a novel siRNA...